 |
ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ -- Thousands of health and technology leaders will gather to share critical health technology insights to optimize care delivery and improve health outcomes at the 2025 HIMSS European Health Conference & Exhibition from 10-12 June in Paris.
HIMSS (the Healthcare Information and Management Systems Society) is a non-profit organization that serves as a global health technology advisor and thought leader dedicated to improving health through information and technology. HIMSS supports health professionals and organizations through education, professional development, networking, and digital maturity assessment tools and advisory services that help transform the global health ecosystem.
At HIMSS25 Europe, powerful speakers, hands-on sessions and data-powered case studies will spur dialogue around artificial intelligence, governance, cybersecurity, workforce development, and digital maturity.
Following the European conference, all eyes turn to upcoming HIMSS conferences across the globe - the 2025 HIMSS APAC Health Conference & Exhibition in July in Kuala Lumpur; and the 2026 HIMSS Global Health Conference & Exhibition in March 2026 in Las Vegas.
HIMSS conferences are part of a global strategy to support healthcare organizations and professionals through a professional society of more than 125,000 members and the HIMSS digital health maturity models – internationally recognized benchmarks to assess and advise health systems in critical areas such as analytics, infrastructure, community care and EMR management.
HIMSS25 Europe: Advancing AI, Health Policy and Cybersecurity
HIMSS25 Europe will be the epicenter for health professionals from more than 70 countries to explore critical themes:
- Artificial intelligence: World-class experts will demonstrate how to effectively and ethically utilize AI in healthcare.
- Regulatory leadership: European officials will dive into the EU AI Act, the Cyber Resilience Act and the European Health Data Space.
- Cybersecurity: Attendees will learn to respond to cyber threats, safeguard patient data and ensure rapid response to cyber risks.
HIMSS25 APAC: Building Momentum
HIMSS25 APAC will continue the global dialogue from 16-18 July in Kuala Lumpur. HIMSS partnered with Informa Markets to co-locate its APAC conference within International Healthcare Week 2025, Southeast Asia's premier healthcare event.
HIMSS25 APAC will strengthen collaboration across health ministries, private sector leaders, clinicians and technology partners. Hundreds of expert speakers will lead discussions, share solutions, and spark ideas to help shape the future of healthcare.
HIMSS26: Global Health Innovation Landing in Las Vegas
Co-produced with Informa Markets, the 2026 HIMSS Global Health Conference & Exhibition will convene a diverse group of digital health experts from 9-12 March 2026 in Las Vegas.
HIMSS26 will feature expanded AI and cybersecurity pavilions, plus workshops on nursing informatics, workforce development, interoperability, and much more.
About HIMSS
HIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in digital health transformation, artificial intelligence, cybersecurity, workforce development, public policy, and research to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our health innovation experts deliver key insights, education, advisory services, and engaging events to healthcare providers, payers, governments, and other health services organizations, ensuring they have the right information at the point of decision.
HIMSS has served the global health community for more than 60 years, with focused operations across Americas, Europe, the United Kingdom, the Middle East and Asia-Pacific. Our members include more than 125,000 individuals and approximately 1,500 provider organizations, nonprofit partners and health services organizations. Our global headquarters is in Rotterdam, The Netherlands, and our Americas headquarters is in Chicago, Illinois. Join our global network at www.himss.org.
Media Contact:
Albe Zakes
HIMSS Communications Director
albe.zakes@himss.org
+1.267.221.4800
ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ -- Thousands of health and technology leaders will gather to share critical health technology insights to optimize care delivery and improve health outcomes at the 2025 HIMSS European Health Conference & Exhibition from 10-12 June in Paris.
HIMSS (the Healthcare Information and Management Systems Society) is a non-profit organization that serves as a global health technology advisor and thought leader dedicated to improving health through information and technology. HIMSS supports health professionals and organizations through education, professional development, networking, and digital maturity assessment tools and advisory services that help transform the global health ecosystem.
At HIMSS25 Europe, powerful speakers, hands-on sessions and data-powered case studies will spur dialogue around artificial intelligence, governance, cybersecurity, workforce development, and digital maturity.
Following the European conference, all eyes turn to upcoming HIMSS conferences across the globe - the 2025 HIMSS APAC Health Conference & Exhibition in July in Kuala Lumpur; and the 2026 HIMSS Global Health Conference & Exhibition in March 2026 in Las Vegas.
HIMSS conferences are part of a global strategy to support healthcare organizations and professionals through a professional society of more than 125,000 members and the HIMSS digital health maturity models – internationally recognized benchmarks to assess and advise health systems in critical areas such as analytics, infrastructure, community care and EMR management.
HIMSS25 Europe: Advancing AI, Health Policy and Cybersecurity
HIMSS25 Europe will be the epicenter for health professionals from more than 70 countries to explore critical themes:
- Artificial intelligence: World-class experts will demonstrate how to effectively and ethically utilize AI in healthcare.
- Regulatory leadership: European officials will dive into the EU AI Act, the Cyber Resilience Act and the European Health Data Space.
- Cybersecurity: Attendees will learn to respond to cyber threats, safeguard patient data and ensure rapid response to cyber risks.
HIMSS25 APAC: Building Momentum
HIMSS25 APAC will continue the global dialogue from 16-18 July in Kuala Lumpur. HIMSS partnered with Informa Markets to co-locate its APAC conference within International Healthcare Week 2025, Southeast Asia's premier healthcare event.
HIMSS25 APAC will strengthen collaboration across health ministries, private sector leaders, clinicians and technology partners. Hundreds of expert speakers will lead discussions, share solutions, and spark ideas to help shape the future of healthcare.
HIMSS26: Global Health Innovation Landing in Las Vegas
Co-produced with Informa Markets, the 2026 HIMSS Global Health Conference & Exhibition will convene a diverse group of digital health experts from 9-12 March 2026 in Las Vegas.
HIMSS26 will feature expanded AI and cybersecurity pavilions, plus workshops on nursing informatics, workforce development, interoperability, and much more.
About HIMSS
HIMSS (Healthcare Information and Management Systems Society) is a global advisor, thought leader and member-based society committed to reforming the global health ecosystem through the power of information and technology. As a mission-driven nonprofit, HIMSS offers a unique depth and breadth of expertise in digital health transformation, artificial intelligence, cybersecurity, workforce development, public policy, and research to advise leaders, stakeholders and influencers across the global health ecosystem on best practices. With a community-centric approach, our health innovation experts deliver key insights, education, advisory services, and engaging events to healthcare providers, payers, governments, and other health services organizations, ensuring they have the right information at the point of decision.
HIMSS has served the global health community for more than 60 years, with focused operations across Americas, Europe, the United Kingdom, the Middle East and Asia-Pacific. Our members include more than 125,000 individuals and approximately 1,500 provider organizations, nonprofit partners and health services organizations. Our global headquarters is in Rotterdam, The Netherlands, and our Americas headquarters is in Chicago, Illinois. Join our global network at www.himss.org.
Media Contact:
Albe Zakes
HIMSS Communications Director
albe.zakes@himss.org
+1.267.221.4800
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
